Impact of Efavirenz-, Ritonavir-Boosted Lopinavir-, and Nevirapine-Based Antiretroviral Regimens on the Pharmacokinetics of Lumefantrine and Safety of Artemether-Lumefantrine in Plasmodium falciparum-Negative HIV-Infected Malawian Adults Stabilized on Antiretroviral Therapy.

导出 OA

翻译打印收藏纠错

第一作者： Clifford G,Banda

第一单位： University of Malawi, College of Medicine, Blantyre, Malawi cgbanda@mlw.mw vmwapasa@medcol.mw.;Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

作者： Clifford G,Banda ^[1] ; Fraction,Dzinjalamala ^[2] ; Mavuto,Mukaka ^[3] ; Jane,Mallewa ^[2] ; Victor,Maiden ^[4] ; Dianne J,Terlouw ^[5] ; David G,Lalloo ^[6] ; Saye H,Khoo ^[7] ; Victor,Mwapasa ^[1]

作者单位： University of Malawi, College of Medicine, Blantyre, Malawi cgbanda@mlw.mw vmwapasa@medcol.mw.;Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi. ^[1] University of Malawi, College of Medicine, Blantyre, Malawi.;Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi. ^[2] University of Malawi, College of Medicine, Blantyre, Malawi.;Oxford Centre for Tropical Medicine and Global Health, Oxford, United Kingdom.;Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand. ^[3] Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi. ^[4] Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.;Liverpool School of Tropical Medicine, Liverpool, United Kingdom. ^[5] Liverpool School of Tropical Medicine, Liverpool, United Kingdom. ^[6] University of Liverpool, Liverpool, United Kingdom. ^[7]

关键词 antimalarial agents antiretroviral therapy artemether-lumefantrine malaria